Twenty‐Four‐Hour Variation of L‐Arginine/Nitric Oxide/Cyclic Guanosine Monophosphate Pathway Demonstrated by the Mouse Visceral Pain Model

References

• Abacioglu N, Zengil H, Uludag O, Tunctan B, Güney Z. Chronorhythmicity of L‐arginine in nociception with the interaction of H1‐receptor blocker mepyramine. Chronobiol Int. 1997; 14: 2
   Google Scholar
• Abacioglu N, Tunctan B, Akbulut E, Cakici I. Participation of the components of L‐arginine/nitric oxide/cGMP cascade by p‐benzoquinone‐induced nociceptive processes in the mouse. Life Sci. 2000; 67: 1127–1137
   PubMed Web of Science ®Google Scholar
• Al‐Sa'doni H, Ferro A. S‐nitrosothiols: a class of nitric oxide‐donor drugs. Clin Sci. 2000; 98: 507–520
   PubMed Web of Science ®Google Scholar
• Bjorkman R. Central antinociceptive effects of non‐steroidal anti‐inflammatory drugs and paracetamol. Experimental studies in the rat. Acta Anaesthesiol Scand. 1995; 103: 1–44
   Google Scholar
• Genesca J, Segura R, Gonzalez A, Catalan R, Marti R, Torregrosa M, Cereto F, Martinez M, Esteban R, Guardia J. Nitric oxide may contribute to nocturnal hemodynamic changes in cirrhotic patients. Am J Gastroenterol. 2000; 95: 1539–1544
   PubMed Web of Science ®Google Scholar
• Globig S, Witte K, Lemmer B. Urinary excretion of nitric oxide, cyclic GMP, and catecholamines during rest and activity period in transgenic hypertensive rats. Chronobiol Int. 1999; 16: 305–314
   PubMed Web of Science ®Google Scholar
• Golombek D A, Agostino P V, Plano S A, Ferreyra G A. Signaling in the mammalian circadian clock: the NO/cGMP pathway. Neurochem Int. 2004; 45: 929–936
   PubMed Web of Science ®Google Scholar
• Güney H Z, Gorgun C Z, Tunctan B, Uludag O, Hodoglugil U, Abacioglu N, Zengil H. Circadian‐rhythm‐dependent effects of L‐NG‐nitroarginine methyl ester (L‐NAME) on morphine‐induced analgesia. Chronobiol Int. 1998; 15: 283–289
   PubMed Web of Science ®Google Scholar
• Kanabrocki E L, Ryan M D, Hermida R C, Ayala D E, Scott G S, Murray D, Bremner W F, Third J L, Johnson M C, Van Foley S, Cauteren J, Shah F, Shirazi P, Nemchausky B A, Hooper D C. Altered circadian relationship between serum nitric oxide, carbon dioxide, and uric acid in multiple sclerosis. Chronobiol Int. 2004; 21: 739–758
   PubMed Web of Science ®Google Scholar
• Kawabata A, Umeda N, Takagi H. L‐Arginine exerts a dual role in nociceptive processing in the brain: involvement of the kyotorphin‐met‐enkephalin pathway and NO‐cyclic GMP pathway. Br. J. Pharmacol. 1993; 109: 73–79
   PubMed Web of Science ®Google Scholar
• Kaya B, Unal S, Karabulut A B, Turkoz Y. Altered diurnal variation of nitric oxide production in patients with panic disorder. Tohoku. J. Exp. Med. 2004; 204: 147–154
   PubMed Web of Science ®Google Scholar
• Kitto K F, Haley J E, Wilcox G L. Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse. Neurosci. Lett. 1992; 148: 1–5
   PubMed Web of Science ®Google Scholar
• Mayer B, Brunner F, Schmidt K. Inhibition of nitric oxide synthesis by methylene blue. Biochem. Pharmacol. 1993; 45: 367–374
   PubMed Web of Science ®Google Scholar
• Mittal C K, Arnold W P, Murad F. Characterization of protein inhibitors of guanylate cyclase activation from rat heart and bovine lung. J. Biol. Chem. 1978; 253: 1266–1271
   PubMed Web of Science ®Google Scholar
• Moore P K, Oluyomi A O, Babbedge R C, Wallace P, Hart S L. L‐NG‐Nitroarginine methyl ester exhibits antinociceptive activity in the mouse. Br. J. Pharmacol. 1991; 102: 198–202
   PubMed Web of Science ®Google Scholar
• Okun R, Liddon S C, Lasagnal L. The effects of aggregation, electric shock, and adrenergic blocking drugs on inhibition of the “writhing syndrome”. J. Pharmacol. Exp. Ther. 1963; 139: 107–109
   PubMed Web of Science ®Google Scholar
• Salter M, Strijbos P JLM, Neale S, Duffy C, Follenfant R L, Garthwaite J. The nitric oxide‐cyclic GMP pathway is required for nociceptive signalling at specific loci within the somatosensory pathway. Neuroscience 1996; 73: 649–655
   PubMed Web of Science ®Google Scholar
• Spessert R, Heil K, Gupta B B, Vollrath L. Biphasic 24‐hour variations in cyclic GMP accumulation in the rat pineal gland are due to corresponding changes in the activity of cytosolic and particulate guanylate cyclase. J Neurochem. 1992; 59: 2081–2086
   PubMed Web of Science ®Google Scholar
• Thippeswamy T, McKay J S, Quinn J P, Morris R. Nitric oxide, a biological double‐faced Janus—is this good or bad?. Histol Histopathol. 2006; 21: 445–458
   PubMed Web of Science ®Google Scholar
• Tischkau S A, Weber E T, Abbott S M, Mitchell J W, Gillette M U. Circadian clock‐controlled regulation of cGMP‐protein kinase G in the nocturnal domain. J Neurosci. 2003; 23: 7543–7550
   PubMed Web of Science ®Google Scholar
• Touitou Y, Smolensky M H, Portaluppi Y. Ethics, standards, and procedures for animal and human chronobiology research. Chronobiol. Int. 2006; 23: 1083–1096
   PubMed Web of Science ®Google Scholar
• Tunctan B, Altug S, Uludag O, Abacioglu N. Time‐dependent variations in serum nitrite, 6‐keto‐prostaglandin F1α and thromboxane B2 levels induced by lipopolysaccharide in mice. Biol Rhythm Res. 2000; 31: 499–514
   Web of Science ®Google Scholar
• Tunctan B, Weigl Y, Dotan A, Peleg L, Zengil H, Ashkenazi I, Abacioglu N. Circadian variation of nitric oxide synthase activity in mouse tissue. Chronobiol. Int. 2002; 19: 393–394
   PubMed Web of Science ®Google Scholar
• Turnbull A V, Rivier C. Corticotropin‐releasing factor, vasopressin, and prostaglandins mediate and nitric oxide restrains the hypothalamic‐pituitary‐adrenal response to acute local inflammation in the rat. Endocrinology 1996; 137: 455–463
   PubMed Web of Science ®Google Scholar
• Uludag O, Tunctan B, Güney H Z, Uluoglu C, Altug S, Zengil H, Abacioglu N. 24 h temporal variation in serum nitrite levels of two different species. Chronobiol. Int. 1999; 16: 527–532
   PubMed Web of Science ®Google Scholar
• Weber E T, Gannon R L, Michel A M, Gilette M U, Rea M A. Nitric oxide synthase inhibitor blocks light‐induced phase shifts of the circadian activity rhythm, but not c‐fos expression in the suprachiasmatic nucleus of the syrian hamster. Brain Res. 1995a; 692: 137–142
   PubMed Web of Science ®Google Scholar
• Weber E T, Gannon R L, Rea M A. cGMP‐dependent protein kinase inhibitor blocks light‐induced phase advances of circadian rhythms in vivo. Neurosci. Lett. 1995b; 197: 227–230
   PubMed Web of Science ®Google Scholar
• Witte K, Schnecko A, Zuther P, Lemmer B. Contribution of the nitric oxide‐guanylyl cyclase system to circadian regulation of blood pressure in normotensive Wistar‐Kyoto rats. Cardiovasc Res. 1995; 30: 682–688
   PubMed Web of Science ®Google Scholar